All News

Isolating and comparing cancer stem cells with their normal counterparts has allowed researchers to identify hundreds of differences that can be used to target therapies, said Elaine Fuchs, PhD, an investigator at the Howard Hughes Medical Institute at the Rockefeller University.

Discussing out-of-pocket costs with patients and how they can deal with the costs is critical for physicians, Yousuf Zafar, MD, MHS, associate professor of medicine at the Duke Cancer Institute and the Duke Clinical Research Institute, said at the 56th ASH Annual Meeting in San Francisco, California, from December 6-9.

Data breaches are expected to increase in 2015, with healthcare "a vulnerable and attractive target for cybercriminals," according to Experian's 2015 Data Breach Industry Forecast.

Financial incentives and the need to share patient information are the top motivations for physicians adopting electronic health records, according to a data brief from the Office of the National Coordinator for Health Information Technology.

Jon White, who in October was named acting chief medical officer for the Office of the National Coordinator for Health IT, on Monday was announced as the agency's acting deputy national coordinator as it searches for a replacement for the recently departed Jacob Reider.

For 2015, marketplaces' ability to conduct an effective renewal process for current enrollees is constrained by their information technology capacity, the short time period for open enrollment, and limited resources for outreach and consumer assistance.

Miscommunication among caregivers is one of the largest causes of medical errors, but a new study suggests that the problem is at least partly preventable.

The Sunshine State seeks to hold down costs with managed care for its Medicaid population and seniors, but it's meeting resistance.

Optimal use of pharmaceuticals is often overlooked for accountable care organizations (ACOs), but ensuring proper medication use, efficacy, and safety is critical to an ACO's success.

The results were presented at the recent Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, a meeting jointly sponsored by the NCI, AACR, and EORTC.

While ASCO is calling to update the 340B drug discount program, hospitals that serve economically diverse populations make a case for the program: "Because of 340B, we don't have to turn patients away when they can't pay."

The American Society of Hematology has added 5 more recommendations to it's Choosing Wisely list, which was published in the journal Blood,

With the share of Medicaid beneficiaries enrolled in managed care past the halfway mark, a new online tool from the Kaiser Family Foundation will help policymakers and researchers track its status in 39 states.

Health information exchange (HIE) use is increasing in the US, but other than reducing emergency department usage and costs, little else is known about the effect of HIEs on other outcomes, according to a new study from RAND.

The study, published in NEJM, found that PFS improved by nearly 4 months while ORR improved by nearly 30%.

By distinguishing low- and intermediate-risk patients, Oncotype DX is predicted to avoid over- and under-treatment of prostate cancer patients.

The 3.6% increase in US healthcare spending in 2013 marks the lowest growth in healthcare spending since 1960, according to a report from CMS published in Health Affairs.

Blincyto, which was considered a promising immunotherapy with a novel mechanism of action, was approved 5 months prior to its PDUFA date.

The National Institutes of Health issued a draft policy today to promote the use of single institutional review boards in multi-site clinical research studies.

Patients on exchange plans are more likely to see higher out-of-pocket costs for their specialty drugs in 2015 compared with 2014, according to a new analysis from Avalere Health.

Rules issued today will help CMS keep fraudulent providers and suppliers away from Medicare, following a series of crackdowns in "hot spots" around the country.

Absence of a microRNA in TNBC resulted in the overexpression of RASAL2 in those tumors. Patients overexpressing RASAL2 had poorer survival, research showed.

People could be putting their lives at risk by dismissing potential warning signs of cancer as less serious symptoms, according to a Cancer Research UK-funded study published in PLOS ONE. The survey found that nearly 97% of people with symptoms failed to act on them.

Although there are no current cases of Ebola in the United States, an increased number of hospitals are now equipped to treat patients with the virus while minimizing risk to healthcare workers.

A study found new indications for a drug that is widely used in the treatment of osteoarthritis, based on an observation that those on the medication had a lower incidence of several cancers.

The 3-year pilot is expected to reel-in significant cost savings for Medicare, which has seen a lot of fraudulent charges with services and equipment.

Employers and employees are seeing eye-to-eye when it comes to integrated health benefits. Not only do employees see how an integrated plan can improve quality of care and health, but employers see how it makes good business sense.

Efforts to improve patient safety in hospitals are paying off: there were 1.3 million fewer adverse events harming patients in 2011, 2012, and 2013, according to a new report from HHS.

President Obama is scheduled to visit NIH today to highlight recent results on a potential Ebola vaccine, developed with GlaxoSmithKline. He is expected to call on Congress to pass a $6.2 billion package to combat the current crisis and prevent future outbreaks.